Database Member Home
RAS Member Home
Key opinion leaders (KOL) play a significant role in a biopharmaceutical product’s development by providing clinical and scientific expertise during initial phase, influencing peers and serving as advocates and spokespersons at product launch. However, increasing regulatory restrictions have forced biopharmaceutical companies to reassess their approach to KOL management.
This video provides guidelines for effective KOL development and engagement to promote long term viability. It discusses the strategic approaches to thought leader management to be adopted by an organization as it evolves, KOL management responsibility in the organization and interpreting the impact of legislative changes on business operations.
Insights from this video will help Medical Affairs professionals in comparing their approach to Key Opinion Leader management against industry standards and identify scope for improvement.
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders... (ID POP-267)
Read More »
Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities... (ID POP-253)
Pharmaceutical and life science companies rely heavily on key opinion leaders (KOLs) to improve their credibility in the marketplace... (ID PSM-235)
Pharmaceutical and medical device organizations seek strategic insights and guidance to successfully navigate the complexities of the changing healthcare landscape... (ID PSM-319)